期刊文献+

^(90)Y电沉积的实验研究 被引量:6

Milking Medical ^(90)Y From ^(90)Sr Solution by Electrodeposition
下载PDF
导出
摘要 研究了用电沉积方法从90Sr母液中分离医用90Y的工艺条件。以0.1 mol/L pH 2.5的(NH4)2SO4溶液为电沉积底液,以铂为阳极,铂或不锈钢为阴极,控制阴极电流密度为0.5 A/cm2,电沉积50 min后,90Y在阴极沉积率>95%。阴极上的90Y用0.1~0.5 mol/L的热硝酸洗脱后再次电沉积。二次电沉积后90Y与90Sr的分离系数>8×105,90Y洗脱收率>70%。铂丝阴极上的90Y可用200~400μL,0.1~0.5 mol/L的热硝酸洗脱,制成用于标记药物的90Y溶液;沉积有90Y的不锈钢阴极经热处理后,制成心血管放射性支架或医用敷贴器,其90Y的日浸出率分别<1%和0.1%。残液中的90Sr经放置约20 d后,可用于再次分离90Y。 The technique of separating ^90y from ^90 Sr cow by electrodeposition was studied using 0. 1 mol/L pH 2.5 (NH4)2SO4 as electrodeposition solution, platinum as anode, platinum or stainless steel as cathode, the current density of cathode 0.5 A/cm^2. After electrodeposition for 50 minutes, more than 95 % ^90y were deposited quantitatively on the cathode. Though two-step electrodepositon, the ^90y/^90 Sr separative coefficient and elution recovery of ^90y were more than 8 × 10^5 and 70% respectively. The ^90y deposited on platinum cathode was eluted by 200-400μL of 0. 1~0.5 mol/L hot HNO3, which was used to label monoclonal antibodies and peptide-receptor. The stainless steel cathode with deposited ^90y can be prepared to radioactive stent or medical patch, the daily leaching efficiency of ^90y were less than 1% and 0.1% respectively. ^90 Sr remained in the deposition solution will generate new ^90y again .
出处 《同位素》 CAS 北大核心 2007年第3期159-163,共5页 Journal of Isotopes
关键词 电沉积 ^90Y ^90SR 分离系数 electrodeposition ^90 y ^90 Sr separative coefficient
  • 相关文献

参考文献9

二级参考文献51

  • 1田国新,梁俊福.TRPO处理高放废液过程中α核素的分离、测定方法[J].核化学与放射化学,1996,18(2):122-128. 被引量:3
  • 2[1]Calif RM,Fortin DF,Frid DJ,et al. Restenosis After Cornonary Angioplasty: an Overview[J]. J Am Coll Cardiol, 1991,17:2B~13B.
  • 3[2]Bottcher HD,Schopohl B,Liermann D, et al. Endovascular Irradiation--a New Method to Avoid Recurrent Stenosis After Stent Implantation in Peripheral Arteries:Technique and Preliminary Results[J]. Int J Radiat Oncol Biol Phys, 1994,29:183~186.
  • 4[3]Fischell RE, Fischell TA. Intra-arterial With the Capability to Inhibit Intimal Hyperplasia[P]. US Patent:5059166, 1991-10-22.
  • 5[4]Hehrlein C, Golllan C, Donges K, et al. Low-dose Radioactive Endovascular Stents Prevent Smooth Muscle Cell Proliferation and Neointimal Hyperplasia in Rabbits[J]. Circulation,1995, 92:1 570~1 575.
  • 6[5]Hehrlein C, Stintz M, Kinscherf R, et al. Pure Beta-particle Emiitting Stents Inhibit Neointima Formation in Rabbits[J]. Circulation, 1996,93:641~645.
  • 7[6]Schulz C, Niederer C, Andres C, et al. Endovascular Irradiation From β-particle-emitting Gold Stents Results in Increased Neointimal Formation in a Porcine Restenosis Model[J]. Circulation, 2000, 101:1 970~1 975.
  • 8[7]Watanabe S, Osa A, Sekine T, et al. Production of Radioactive Endovascular Stents by Implantation of 133Xe Ions[J]. Appl Radiat Isot, 1999,51(2):197~202.
  • 9[8]Hafeli UO, Warburton MC, Landau U. Electro-deposition of Radioactive Rhenium Onto Stents to Prevent Restenosis[J]. Biomaterials, 1998,19:925~933.
  • 10[9]Janicki C, Duggan DM, Coffey CW, et al. Radiation Dose From a Phosphorous-32 Impregnated Wire Mesh Vascular Stent[J]. Med Phys, 1997, 24:437~445.

共引文献25

同被引文献55

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部